Newcells Biotech receives £2m to advance stem cell research
Newcells Biotech announced that it has received £2m ($2.64m) from NVM Private Equity and Northstar Ventures.
Archives for July 4, 2018
Abzena signs $5.9m manufacture agreement with Telix
Abzena has revealed that it has signed a GMP manufacturing and bioconjugation deal with Telix worth $5.9m.
Rubius Therapeutics to build $155m facility in Rhode Island
Rubius Therapeutics says it will invest $155m over five years in a new manufacturing facility and biotech operations in Rhode Island, US.